EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY 4.0

Clinical Impact of HRCT UIP Pattern Among Patients With Idiopathic Pulmonary Fibrosis Undergoing Antifibrotic Treatment: A Multicenter Retrospective Observational Study

Satoshi Nagaoka iD, Yu Hara iD, Hiroaki Fujii iD, Kota Murohashi, Ryo Nagasawa, Yoichi Tagami iD, Yusuke Saigusa, Tatsuji Enomoto, Yutaka Matsumoto, Makoto Masuda iD, Nobuyuki Horita iD, Masaki Yamamoto iD und 4 weitere

Canadian Respiratory Journal · 2026

DOI: 10.1155/carj/3604892 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Canadian Respiratory Journal, 2026. Verfasst von Satoshi Nagaoka und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura Kanazawa-ku, Yokohama 236-0004, Kanagawa, Japan, yokoham…. Hauptthemen laut MEDLINE: Idiopathic Pulmonary Fibrosis, Tomography, X-Ray Computed, Antifibrotic Agents. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Idiopathic pulmonary fibrosis (IPF) is a progressive fibrosing interstitial lung disease with a poor prognosis. Honeycombing on high‐resolution computed tomography (HRCT) is a defining feature of the usual interstitial pneumonia (UIP) pattern and has traditionally been considered a marker of advanced disease. However, in the era of antifibrotic treatment (AFT), the prognostic significance of the UIP pattern in IPF remains uncertain. This study aimed to evaluate the association between HRCT UIP pattern and long‐term prognosis in patients with IPF receiving AFT.

Methods

This retrospective multicenter study investigated consecutive patients with IPF who initiated AFT between 2009 and 2019 at seven institutions in Japan. HRCT patterns were classified as UIP or non‐UIP by multidisciplinary assessment. The primary outcome was IPF‐related events, defined as IPF‐related death or first acute exacerbation (AE) after initiating AFT. Event‐free survival was analyzed using Kaplan–Meier methods with stratification by gender–age–physiology (GAP) stage. Propensity score matching (PSM) was performed to adjust for age, sex, GAP score, and antifibrotic agent.

Results

Of the 139 patients included, 99 had a UIP pattern, and 40 had a non‐UIP pattern. In the overall cohort, event‐free survival did not differ significantly. Stratified analyses showed no significant survival difference between UIP and non‐UIP patterns among GAP Stage I patients (median survival time [MST]: 2050 vs. 1104 days; p = 0.90). Similarly, among patients with GAP Stages II–III, MST did not differ significantly. After PSM, 34 matched pairs were analyzed, and no significant differences in event‐free survival were observed between UIP and non‐UIP patterns.

Conclusions

In patients with IPF treated with AFT, the radiological UIP pattern on HRCT was not independently associated with long‐term prognosis. Multidimensional risk assessment incorporating physiological impairment and disease behavior may provide more accurate prognostic stratification in treated UIP populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Idiopathic Pulmonary FibrosisTomography, X-Ray ComputedAntifibrotic AgentsHumansMaleRetrospective StudiesFemaleAgedPrognosisJapanIndolesMiddle AgedPyridonesDisease Progression

Stichwörter der Autor:innen

antifibrotic treatmentidiopathic pulmonary fibrosisnintedanibpirfenidoneusual interstitial pneumonia

Substanzen

Antifibrotic AgentspirfenidonenintedanibIndolesPyridones

Autor:innen und Institutionen

  • Department of Pulmonology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura Kanazawa-ku, Yokohama 236-0004, Kanagawa, Japan, yokohama-cu.ac.jp.
  • Department of Pulmonology, Yokohama Minami Kyousai Hospital, 1-21-1 Mutsuurahigasi Kanazawa-ku, Yokohama 236-0037, Kanagawa, Japan, minamikyousai.jp.
  • Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, 6-16-1 Tomioka-higashi Kanazawa-ku, Yokohama 236-0051, Kanagawa, Japan.
  • Department of Biostatistics, Yokohama City University Graduate School of Medicine, 3-9 Fukuura Kanazawa, Yokohama 236-0004, Japan, yokohama-cu.ac.jp.
  • Department of Respiratory Medicine, Ofuna Chuo Hospital, 6-2-24 Ofuna, Kamakura 247-0056, Kanagawa, Japan, ofunachuohp.net.
  • Department of Respiratory Medicine, Yamato Municipal Hospital, 8-3-6 Fukami-nishi, Yamato 242-8602, Kanagawa, Japan.

ORCID-Profile: Satoshi Nagaoka, Yu Hara, Hiroaki Fujii, Yoichi Tagami, Makoto Masuda, Nobuyuki Horita, Masaki Yamamoto, Nobuaki Kobayashi, Takashi Ogura, Makoto Kudo

Zitieren

APA

Nagaoka, S., Hara, Y., Fujii, H., Murohashi, K., Nagasawa, R., Tagami, Y., Saigusa, Y., Enomoto, T., Matsumoto, Y., Masuda, M., Horita, N., Yamamoto, M., Kobayashi, N., Ogura, T., Kaneko, T., & Kudo, M. (2026). Clinical Impact of HRCT UIP Pattern Among Patients With Idiopathic Pulmonary Fibrosis Undergoing Antifibrotic Treatment: A Multicenter Retrospective Observational Study. Canadian Respiratory Journal. https://doi.org/10.1155/carj/3604892

Vancouver

Nagaoka S, Hara Y, Fujii H, Murohashi K, Nagasawa R, Tagami Y, et al. Clinical Impact of HRCT UIP Pattern Among Patients With Idiopathic Pulmonary Fibrosis Undergoing Antifibrotic Treatment: A Multicenter Retrospective Observational Study. Canadian Respiratory Journal. 2026. doi:10.1155/carj/3604892

BibTeX
@article{Nagaoka2026,
  author = {Nagaoka, Satoshi and Hara, Yu and Fujii, Hiroaki and Murohashi, Kota and Nagasawa, Ryo and Tagami, Yoichi and Saigusa, Yusuke and Enomoto, Tatsuji and Matsumoto, Yutaka and Masuda, Makoto and Horita, Nobuyuki and Yamamoto, Masaki and Kobayashi, Nobuaki and Ogura, Takashi and Kaneko, Takeshi and Kudo, Makoto},
  title = {Clinical Impact of HRCT UIP Pattern Among Patients With Idiopathic Pulmonary Fibrosis Undergoing Antifibrotic Treatment: A Multicenter Retrospective Observational Study},
  journal = {Canadian Respiratory Journal},
  year = {2026},
  doi = {10.1155/carj/3604892}
}
Kostenlos starten →